Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRC2.L Regulatory News (RC2)

  • There is currently no data for RC2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Unaudited Financial Statements

20 Aug 2018 09:16

RNS Number : 2764Y
Reconstruction Capital II Ltd
20 August 2018
 

20 August 2018

Reconstruction Capital II Limited (the "Company")

Interim Unaudited Financial Statements

for the six months ended 30 June 2018

 

Reconstruction Capital II Limited ("RC2", the "Company" or the "Group"), a closed-end investment company incorporated in the Cayman Islands admitted to trading on the AIM market of the London Stock Exchange, today announces its results for the six months ended 30 June 2018.

Copies of the company's interim financial statements will today be posted to shareholders. The interim report is also available on the Company's website http://www. reconstructioncapital2.com/.

Financial highlights

On 30 June 2018, Reconstruction Capital II Limited ("RC2") had a total unaudited net asset value ("NAV") of €35.7m or €0.2463 per share, which represents a 1.61% fall since the beginning of the year.

At a general meeting of shareholders held on 21 February 2018 a decision was made to acquire 22% of the issued share capital of Reconstruction Capital Plc (RC) for €1.6m and 10% of the issued share capital of The Romanian Investment Fund Limited (RIF) for €1.7m. Both funds are Romanian-focused and have as their main underlying asset a 60% shareholding in Policolor SA in which RC2 already owns the balance of 40%. RC2 now has a further 15.36% indirect shareholding as a result of these acquisitions. To date, only part of the acquisition has been settled for €1.1m, the balance of €2.1m being due once the vendors have resolved certain technical issues for settlement.

As at 30 June 2018, RC2 had cash and cash equivalents of approximately €4.6m while its wholly-owned subsidiary RC2 Cyprus Ltd had cash and cash equivalents of €2.3m. As at 30 June 2018, RC2 had sundry liabilities of €2.3m, including the €2.1m due for the settlement of the acquisitions of shares in RC and RIF.

Operational highlights

In May, Policolor signed an amendment to the sales contract with the buyers of its main site in Bucharest, bringing forward the sale of 4.4ha of its remaining 7.6ha from 2019 to 2018. The land being sold in 2018 has been divided into three plots, with the first plot already having been sold in May generating cash proceeds of €1.4m. A second plot of land was sold in July, generating proceeds of €1.5m, and a further 2.2ha is due to be sold in the autumn, generating cash proceeds of €3m. In May, Policolor also signed the contract for the construction of its new Bucharest plant, which is due to be completed in the spring of 2019 and to become operational in the summer of that year.

Operationally, the Policolor Group had a reasonable first half of the year with sales marginally ahead of the same period last year at €33.3m (cf. 2017 €32.9m), whilst EBITDA fell by 10.6% to €1.95m compared to the same period of the previous year.

The fair value of the investments held under the Private Equity Programme increased by €3.4m to €33.6m during the period, primarily due to the acquisition of the shares in RC and RIF detailed above.

For further information, please contact:

Reconstruction Capital II Limited

Cornelia Oancea / Anca Moraru

Tel: +40 21 316 76 80

 

Grant Thornton UK LLP

(Nominated Adviser)

Philip SecrettTel: +44 (0) 20 7383 5100

 

finnCap Limited

(Broker)

William Marle / Giles Rolls

Tel: +44 20 7220 0500

 

 

 

 

 

 

 

 

 

ADVISER'S REPORT

 

For the six months ended 30 June 2018

 

On 30 June 2018, Reconstruction Capital II Limited ("RC2") had a total unaudited net asset value ("NAV") of €35.7m or €0.2463 per share, which represents a 1.61% fall since the beginning of the year.

 

At a general meeting of shareholders held on 21 February 2018 a decision was made to acquire 22% of the issued share capital of Reconstruction Capital Plc (RC) for €1.6m and 10% of the issued share capital of The Romanian Investment Fund Limited (RIF) for €1.7m. Both funds are Romanian-focused and have as their main underlying asset a 60% shareholding in Policolor SA in which RC2 already owns the balance of 40%. RC2 now has a further 15.36% indirect shareholding as a result of these acquisitions. To date, only part of the acquisition has been settled for €1.1m, the balance of €2.1m being due once the vendors have resolved certain technical issues for settlement.

 

As at 30 June 2018, RC2 had cash and cash equivalents of approximately €4.6m while its wholly-owned subsidiary RC2 Cyprus Ltd had cash and cash equivalents of €2.3m. As at 30 June 2018, RC2 had sundry liabilities of €2.3m, including the €2.1m due for the settlement of the acquisitions of shares in RC and RIF.

 

In May, Policolor signed an amendment to the sales contract with the buyers of its main site in Bucharest, bringing forward the sale of 4.4ha of its remaining 7.6ha from 2019 to 2018. The land being sold in 2018 has been divided into three plots, with the first plot already having been sold in May generating cash proceeds of €1.4m. A second plot of land was sold in July, generating proceeds of €1.5m, and a further 2.2ha is due to be sold in the autumn, generating cash proceeds of €3m. In May, Policolor also signed the contract for the construction of its new Bucharest plant, which is due to be completed in the spring of 2019 and to become operational in the summer of that year.

 

Operationally, the Policolor Group had a reasonable first half of the year with sales marginally ahead of the same period last year at €33.3m (cf. 2017 €32.9m), whilst EBITDA fell by 10.6% to €1.95m compared to the same period of the previous year.

 

The fair value of the investments held under the Private Equity Programme increased by €3.4m to €33.6m during the period, primarily due to the acquisition of the shares in RC and RIF detailed above.

New Europe Capital SRL

 

STATEMENT OF COMPREHENSIVE INCOME

 

For the six months ended 30 June 2018

 

 

 

30 June

 

30 June

 

31 December

 

 

2018

2017

2017

 

 

EUR

 

EUR

 

EUR

 

 

Unaudited

 

Unaudited

 

Audited

Revenue

 

 

 

 

 

 

Fair value loss on financial assets at

 

 

 

 

 

 

fair value through profit or loss

 

(2,077,374)

(4,011,373)

(10,981,533)

Recovery of previously written off

 

 

 

 

 

 

receivable

 

-

-

189,000

Interest income

 

2,153,054

2,146,080

4,334,820

Dividend income

 

-

3,500,000

7,619,610

Other income

 

10

-

-

 

 

 

 

 

 

 

Total revenue

 

75,690

1,634,707

1,161,897

Expenses

 

 

 

 

 

 

 

(126,000)

-

-

Impairment on trade and other receivables

Operating expenses

 

(534,322)

(1,096,874)

(1,619,749)

Financial expenses

 

(721)

(200)

(188)

 

 

 

 

 

 

 

Total expenses

 

(661,043)

(1,097,074)

(1,619,937)

 

 

 

 

 

 

 

Profit for the period/year

 

(585,353)

537,633

(458,040)

 

 

 

 

 

 

 

Other comprehensive income

 

-

-

-

Total comprehensive income for

 

 

 

 

 

 

 

(585,353)

537,633

(458,040)

the period/year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings Per Share attributable to

 

 

 

the owners of the Company

 

 

Basic and diluted earnings per share

(0.0040)

0.0037

(0.0031)

 

 

 

 

STATEMENT OF FINANCIAL POSITION

As at 30 June 2018

 

 

 

 

30 June

 

30 June

 

31 December

 

 

 

2018

2017

2017

 

 

EUR

 

EUR

 

EUR

 

 

 

Unaudited

 

Unaudited

 

Audited

ASSETS

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

Financial assets at fair value through

 

 

 

 

 

 

 

profit or loss

 

 

33,568,867

34,804,972

30,143,162

 

 

 

 

 

 

 

 

Total non-current assets

 

 

33,568,867

34,804,972

30,143,162

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade and other receivables

 

18,281

50,564

136,439

Cash and cash equivalents

 

 

4,567,668

3,028,792

6,439,763

 

 

 

 

 

 

 

 

Total current assets

 

 

4,585,949

3,079,356

6,576,202

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

 

38,154,816

37,884,328

36,719,364

LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

Trade and other payables

 

2,451,315

335,779

430,510

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

2,451,315

335,779

430,510

 

 

 

 

 

 

 

 

NET ASSETS

 

 

35,703,501

37,548,549

36,288,854

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EQUITY ATTRIBUTABLE TO OWNERS

 

 

 

 

 

Share capital

 

 

1,449,460

1,465,223

1,449,460

Share premium

 

 

110,581,355

110,829,614

110,581,355

Retained deficit

 

 

(76,327,314)

(74,746,288)

(75,741,961)

 

 

 

 

 

 

 

 

TOTAL EQUITY

 

 

35,703,501

37,548,549

36,288,854

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Asset Value per share

 

 

 

 

Basic and diluted net asset value per

 

 

 

 

share

0.2463

0.2563

0.2504

 

 

 

STATEMENT OF CHANGES IN EQUITY

 

For the six months ended 30 June 2018

 

 

 

 

 

 

Retained

 

Equity

 

 

 

 

 

Share

 

(deficit)/

 

component of

 

 

 

Share capital

 

premium

 

earnings

 

loan notes

 

Total

 

EUR

 

EUR

 

EUR

 

EUR

 

EUR

Balance at 1 January 2017

1,476,223

127,991,989

(75,283,921)

-

54,184,291

Profit for the period

-

-

537,633

-

537,633

Other comprehensive income

-

-

-

-

-

 

 

 

 

 

 

 

 

 

 

Total comprehensive income for the period

-

-

537,633

-

537,633

 

 

 

 

 

 

 

 

 

 

Issue of B shares

16,997,375

(16,997,375)

-

-

-

Redemption of B shares

(16,997,375)

-

-

-

(16,997,375)

Repurchase and cancellation of own shares

(11,000)

(165,000)

-

-

(176,000)

 

 

 

 

 

 

 

 

 

 

Transactions with owners

(11,000)

(17,162,375)

-

-

(17,173,375)

Balance at 30 June 2017

 

 

 

 

 

 

 

 

 

1,465,223

110,829,614

(74,746,288)

-

37,548,549

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss for the period

-

-

(995,673)

-

(995,673)

Other comprehensive income

-

-

-

-

-

 

 

 

 

 

 

 

 

 

 

Total comprehensive income for the period

-

-

(995,673)

-

(995,673)

 

 

 

 

 

 

 

 

 

 

Repurchase and cancellation of own shares

(15,763)

(248,259)

-

-

(264,022)

 

 

 

 

 

 

 

 

 

 

Transactions with owners

(15,763)

(248,259)

-

-

(264,022)

Balance at 31 December 2017

 

 

 

 

 

 

 

 

 

1,449,460

110,581,355

(75,741,961)

-

36,288,854

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the period

-

-

(585,353)

-

(585,353)

Other comprehensive income

-

-

-

-

-

 

 

 

 

 

 

 

 

 

 

Total comprehensive income for the period

-

-

(585,353)

-

(585,353)

Balance at 30 June 2018

 

 

 

 

 

 

 

 

 

1,449,460

110,581,355

(76,327,314)

-

35,703,501

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CASH FLOW STATEMENT

For the six months ended 30 June 2018

 

30 June

 

30 June

 

31 December

 

 

2018

2017

2017

 

 

EUR

 

EUR

 

EUR

 

 

Unaudited

 

Unaudited

 

Audited

 

Cash flows (used in)/generated from operating

 

 

 

 

 

 

activities

(585,353)

537,633

(458,040)

 

Profit/(loss) before taxation

 

Adjustments for:

 

 

 

 

 

 

Fair value loss on financial assets at fair value

2,077,374

4,011,373

10,981,533

 

through profit or loss

 

Impairment on trade and other receivables

126,000

-

-

 

Reversal of loan impairment

-

-

(189,000)

 

Interest income

(2,153,054)

(2,146,080)

(4,334,820)

 

Dividend income

-

(3,500,000)

(7,619,610)

 

Net loss on foreign exchange

721

200

188

 

Net cash outflow before changes in working

 

 

 

 

 

 

(534,312)

(1,096,874)

(1,619,749)

 

capital

 

(Increase)/decrease in trade and other receivables

(7,842)

(32,773)

7,352

 

(Decrease)/increase in trade and other payables

(83,686)

43,377

138,108

 

Purchase of financial assets

(1,224,079)

(370,000)

(370,000)

 

Disposals and repayments of financial assets

-

-

63,000

 

Dividends received

-

3,500,000

7,500,000

 

Net cash (used in)/generated from operating

 

 

 

 

 

 

(1,849,919)

2,043,730

5,718,711

 

activities

 

Cash flows used in financing activities

 

 

 

 

 

 

-

(176,000)

(440,022)

 

Payments to purchase own shares

 

Redemptions of B shares

(21,455)

(16,842,979)

(16,842,979)

 

 

 

 

 

 

 

 

Net cash flow used in financing activities

(21,455)

(17,018,979)

(17,283,001)

 

Net decrease in cash and cash equivalents

 

 

 

 

 

 

(1,871,374)

(14,975,249)

(11,564,290)

 

before currency adjustment

 

Effects of exchange rate differences on cash and

(721)

(200)

(188)

 

cash equivalents

 

Net decrease in cash and cash equivalents after

 

 

 

 

 

 

(1,872,095)

(14,975,449)

(11,564,478)

 

currency adjustment

 

Cash and cash equivalents at the beginning of the

6,439,763

18,004,241

18,004,241

 

period/year

 

Cash and cash equivalents at the end of the

 

 

 

 

 

 

4,567,668

3,028,792

6,439,763

 

period/year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR PGUPGRUPRURU
Date   Source Headline
28th Aug 20144:06 pmRNSNet Asset Value and Monthly Report
26th Aug 20149:34 amRNSQuarterly Report
22nd Aug 20147:00 amRNSInterim Results
25th Jul 20144:39 pmRNSNet Asset Value
7th Jul 20141:30 pmRNSConvertible Loan Update and Bridge Loan Extension
3rd Jul 20149:38 amRNSDirector Shareholding
30th Jun 20144:55 pmRNSNet Asset Value and Monthly Report
20th Jun 201412:07 pmRNSDirector Shareholding
18th Jun 20147:00 amRNSAnnual Results for 31 December 2013
2nd Jun 20145:05 pmRNSMonthly Report and Net Asset Value
2nd Jun 20145:00 pmRNSQuarterly Report
29th Apr 201410:45 amRNSNet Asset Value(s)
28th Apr 201410:37 amRNSDirector/PDMR Shareholding
17th Apr 20144:17 pmRNSNet Asset Value & Monthly Report
11th Apr 201410:50 amRNSNet Asset Value and Monthly Report
9th Apr 201411:49 amRNSDirector Shareholding
24th Mar 201411:39 amRNSQuarterly Report
13th Mar 20144:36 pmRNSNew Valuations of Private Equity Positions
24th Feb 20141:39 pmRNSDirector Shareholding
19th Feb 20145:40 pmRNSInvestment update
20th Dec 20132:29 pmRNSNet Asset Value and Monthly Report
13th Dec 201312:03 pmRNSDirector Shareholding Replacement
13th Dec 20138:28 amRNSDirector Shareholding
10th Dec 20139:43 amRNSDirector Shareholding
4th Dec 201310:48 amRNSDirector Shareholding
27th Nov 201310:00 amRNSDirector Shareholding
27th Nov 20139:56 amRNSNet Asset Value and Monthly Report
26th Nov 20139:24 amRNSResignation of Director
18th Nov 201310:14 amRNSQuarterly Report
18th Oct 201311:18 amRNSNet Asset Value
1st Oct 201310:04 amRNSNet Asset Value and Monthly Report
16th Sep 20134:45 pmRNSDirector Shareholding
4th Sep 20134:22 pmRNSInterim results
23rd Aug 20138:38 amRNSNet Asset Value and Monthly Report
9th Aug 20135:36 pmRNSQuarterly Report
29th Jul 20134:42 pmRNSNet Asset Value(s)
9th Jul 201311:48 amRNSDirector Shareholding
8th Jul 20139:22 amRNSDirector Shareholding
2nd Jul 20131:45 pmRNSNet Asset Value
28th Jun 20137:00 amRNSAnnual Results for 31 December 2012
24th Jun 20132:32 pmRNSNew Valuations of Private Equity Positions
17th May 20135:31 pmRNSNet Asset Value and Portfolio Update
30th Apr 20131:37 pmRNSNet Asset Value and Quarterly Report
12th Apr 20132:30 pmRNSInvestment in Orgachim
4th Apr 20137:00 amRNSNet Asset Value and Monthly Report
6th Mar 20137:50 amRNSNet Asset Value(s)
26th Feb 201310:09 amRNSQuarterly Report
4th Feb 201310:34 amRNSNet Asset Value
21st Dec 20122:44 pmRNSNet Asset Value and Monthly Report
14th Dec 20123:20 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.